According to Bound Tree Medical's Stacey Barksdale Price, Manager of EMS Pharmaceuticals and IV Therapy, "The epinephrine 1:10,000 shortage is of highest concern as both Hospira and IMS are restricting quantities that they are releasing. They are releasing product intermittently, but it is not at the levels that meet customer demand. Both companies project this allocation status to remain in effect on this and other prefilled syringes through September."

>> Click to review the latest weekly EMS pharmaceutical and IV backorder report.